TIMELY Trial Reaches Key Enrollment Milestone at Klinik Königsfeld

The TIMELY clinical trial has achieved a significant milestone at our study center in Klinik Königsfeld, Germany. The center has successfully enrolled all the patients required for the randomized controlled trial, marking a pivotal step forward in the project's timeline.

The TIMELY trial is focused on developing and implementing a comprehensive platform that leverages artificial intelligence to assist both patients and clinicians in personalizing healthcare. This platform will provide real-time risk evaluations, outcome predictions, and tailored interventions, all designed to enhance the management and prevention of coronary artery disease (CAD).

The main hypothesis driving the TIMELY trial is that a modular, collaborative eHealth platform, enhanced by AI for real-time prediction of cardiac risks and complications, can be both effective and cost-efficient in the secondary prevention of CAD. This innovative approach is expected to mitigate the physiological and psychological impacts of the disease while improving the management of risk factors and symptoms.

Stay tuned for more updates as the TIMELY trial progresses on its journey to improve patient outcomes and reshape the landscape of cardiac healthcare.